The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for troriluzole for the treatment of adults with ...
Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections Inspira announced its bio-electronic ...
After hours: February 14 at 7:57:59 PM EST ...
This stock can be held in an Investment ISA and an Investment Account ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback